Cross-Sectional Gender Comparison of Gray Matter Concentration in Prodromal Huntington’s Disease

Cross-Sectional Gender Comparison of Gray Matter Concentration in Prodromal Huntington’s Disease

Huntington’s disease (HD) is a neurodegenerative disorder caused by an abnormal repetition of the cytosine-adenine-guanine (CAG) trinucleotide in the HTT gene. This polyglutamine mutation causes behavioral, cognitive, and motor abnormalities such as chorea. Additionally, HD is characterized by stria...

Full description

Bibliographic Details
Main Authors:	Destiny Ogbu, Jennifer Cairochi, Jane S. Paulsen, Jessica A. Turner
Format:	Article
Language:	English
Published:	Appalachian State University Honors College 2020-06-01
Series:	Impulse: The Premier Undergraduate Neuroscience Journal
Subjects:	gray matter prodromal huntington’s disease magnetic resonance imaging gender hd stage component
Online Access:	https://impulse.appstate.edu/articles/2020/cross-sectional-gender-comparison-gray-matter-concentration-prodromal-huntington’s-dis

Similar Items

Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease
by: Jingyu Liu, et al.
Published: (2018-03-01)

Patterns of Co-occurring Gray Matter Concentration Loss Across the Huntington Disease Prodrome
by: Jennifer Ashley Ciarochi, et al.
Published: (2016-09-01)

An intangible reality: the experience of uncertainty among intimate partners of persons with prodromal huntington disease
by: McGonigal-Kenney, Meghan L.
Published: (2011)

Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease
by: Tarja-Brita Robins Wahlin, et al.
Published: (2015-12-01)

Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease
by: Eileanoir B. Johnson, et al.
Published: (2017-10-01)

High and Low Levels of an NTRK2-Driven Genetic Profile Affect Motor- and Cognition-Associated Frontal Gray Matter in Prodromal Huntington’s Disease
by: Jennifer A. Ciarochi, et al.
Published: (2018-06-01)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
by: Ming-Chyi Pai, et al.
Published: (2021-10-01)

Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder
by: Mariane N. Noto, et al.
Published: (2015-12-01)

Cerebral cortex structure in prodromal Huntington disease
by: Peggy C. Nopoulos, et al.
Published: (2010-12-01)

Applicability of the Chinese Version of the Prodromal Questionnaire
by: Shu-Chen Chiu, et al.
Published: (2010-09-01)

BRAIN GRAY MATTER HETEROTOPIA WITH HEMIPARESIS
by: Wisam Abdullah Jasim
Published: (2012-12-01)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
by: Andreia V. Faria, et al.
Published: (2016-01-01)

PRODROMAL PHASE IN THE DEVELOPMENT OF EARLY ONSET SCHIZOPHRENIC PSYCHOSIS - CASE REPORT
by: Jelena Kostić, et al.
Published: (2012-06-01)

The Prodromal Phase of What? : A Metapsychiatric Analysis of the Prodromal Phase of Schizophrenia
by: Neubeck, Anna-Karin
Published: (2008)

Couples' illness representation and coping procedures in prodromal Huntington disease
by: Downing, Nancy Ruth
Published: (2010)

Animal Model for Prodromal Parkinson’s Disease
by: Tomoyuki Taguchi, et al.
Published: (2020-03-01)

Retrospective evaluation of risk determinants in prodromal period with a group of schizophrenia patients
by: Soner Cakmak, et al.
Published: (2016-09-01)

8OHdG as a marker for Huntington disease progression
by: Jeffrey D. Long, et al.
Published: (2012-06-01)

Study of prodromal and residual symptoms of depression
by: Vishal B Pede, et al.
Published: (2017-01-01)

Editorial: Prodromal Parkinson's Disease
by: David Crosiers, et al.
Published: (2021-01-01)

Optimization of trans-Splicing for Huntington's Disease RNA Therapy
by: Hansjörg Rindt, et al.
Published: (2017-10-01)

White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
by: Nadezda Ivanova, et al.
Published: (2020-01-01)

Pediatric vs. Adult Prodrome and Postdrome: A Window on Migraine Pathophysiology?
by: Jean-Christophe Cuvellier
Published: (2019-03-01)

Gray Matter Correlates of Creativity in Musical Improvisation
by: Cameron Arkin, et al.
Published: (2019-05-01)

Atypical Brain Structures as a Function of Gray Matter Volume (GMV) and Gray Matter Density (GMD) in Young Adults Relating to Autism Spectrum Traits
by: Yu Yaxu, et al.
Published: (2020-04-01)

Microstructural changes in white matter in prodromal and clinical Parkinson’s disease
by: Ohlhauser, Lisa
Published: (2018)

Early Mood Swings as Symptoms of the Bipolar Prodrome: Preliminary Results of a Retrospective Analysis
by: Özgürdal, Seza, et al.
Published: (2014)

Internet addiction, Hikikomori syndrome, and the prodromal phase of psychosis
by: Emmanuel eStip, et al.
Published: (2016-03-01)

Lipid composition of the normal human brain: gray matter, white matter, and myelin*
by: John S. O'Brien, et al.
Published: (1965-10-01)

Clinical and Imaging Markers of Prodromal Parkinson's Disease
by: Eldbjørg Hustad, et al.
Published: (2020-05-01)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
by: Natalia P. Rocha, et al.
Published: (2018-11-01)

Traumatic Brain Injury During the Prodromal Phase of Parkinson’s Disease
by: Halil Önder
Published: (2018-06-01)

Prodrome of Paranoid Schizophrenia with Episodic Type of Course and Schizoaffective Structure of Manifest Episode
by: Alexander S. Bobrov, et al.
Published: (2014-06-01)

Anatomical and diffusion MRI of deep gray matter in pediatric spina bifida
by: Ashley L. Ware, et al.
Published: (2014-01-01)

Prodromal Symptoms in Acute Myocardial Infarction in City of Birjand
by: HR Mashreghimoghadam, et al.
Published: (2008-09-01)

Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
by: Catalina Requejo, et al.
Published: (2020-10-01)

Chorea–Acanthocytosis and the Huntington Disease Allele in an Irish Family
by: Olwen C. Murphy, et al.
Published: (2018-10-01)

Non-motor symptoms and their use as markers for prodromal and early Parkinson's disease
by: Stephens, Aubree
Published: (2021)

Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein
by: Azzam Aladdin, et al.
Published: (2019-10-01)

Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
by: Jannis Achenbach, et al.
Published: (2021-03-01)